{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:59:00Z","timestamp":1775080740710,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/bf03346913","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T16:51:11Z","timestamp":1395939071000},"page":"580-584","source":"Crossref","is-referenced-by-count":12,"title":["Late and transient increases in free T4 after radioiodine treatment for Graves\u2019 disease"],"prefix":"10.1007","volume":"20","author":[{"given":"A. D.","family":"Stensvold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sundsfjord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346913_CR1","first-page":"1638","volume":"34","author":"B Shapiro","year":"1993","unstructured":"Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J. Nucl. Med. 34: 1638, 1993.","journal-title":"J. Nucl. Med."},{"key":"BF03346913_CR2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1259\/0007-1285-59-707-1105","volume":"59","author":"GE Ratcliffe","year":"1986","unstructured":"Ratcliffe G.E., Fogelman I., Maisey MN. The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. Br. J. Radiol. 59: 1105, 1986.","journal-title":"Br. J. Radiol."},{"key":"BF03346913_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bmj.289.6441.361","volume":"289","author":"P Kendall-Taylor","year":"1984","unstructured":"Kendall-Taylor P., Keir MJ., Ross WM. Ablative radioiodine therapy for hyperthyroidism: long term follow-up study. Br. Med. J. 289: 361, 1984.","journal-title":"Br. Med. J."},{"key":"BF03346913_CR4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/bjs.1800601003","volume":"60","author":"WR Greig","year":"1973","unstructured":"Greig W.R. Radioactive iodine therapy for thyrotoxicosis. Br. J. Surg. 60: 758, 1973.","journal-title":"Br. J. Surg."},{"key":"BF03346913_CR5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM196709142771102","volume":"277","author":"GA Hagen","year":"1967","unstructured":"Hagen G.A., Ouellette R.P., Chapman E.M. Comparison of high and low dosage levels of 131I in the treatment of thyrotoxicosis. N. Engl. J. Med. 277: 559, 1967.","journal-title":"N. Engl. J. Med."},{"key":"BF03346913_CR6","first-page":"411","volume":"32","author":"RA Nordyke","year":"1991","unstructured":"Nordyke R.A., Gilbert F.I. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves disease. J. Nucl. Med. 32: 411, 1991.","journal-title":"J. Nucl. Med."},{"key":"BF03346913_CR7","first-page":"21","volume":"94","author":"MT Masri","year":"1995","unstructured":"Masri M.T., Menne M., Rooney B.L., Caplan R.H. A simplified method for treating Graves\u2019 disease with radioactive 131I Wis. Med. J. 94: 21, 1995.","journal-title":"Med. J."},{"key":"BF03346913_CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/030006059202000310","volume":"20","author":"A Zaini","year":"1992","unstructured":"Zaini A., Khir A., Doi S.A.R., Chan S.P., Paramsothy M., Khoo B.H. Results of long-term follow-up after compensated fixed-dose therapy for thyrotoxicosis. J. Int. Med. Res. 20: 279, 1992.","journal-title":"J. Int. Med. Res."},{"key":"BF03346913_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1991.tb01738.x","volume":"34","author":"JA Franklyn","year":"1991","unstructured":"Franklyn J.A., Daykin J., Drolc Z., Farmer M., Sheppard M.C. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin. Endocrinol. 34: 71, 1991.","journal-title":"Clin. Endocrinol."},{"key":"BF03346913_CR10","first-page":"978","volume":"23","author":"AJ Cunnien","year":"1982","unstructured":"Cunnien A.J., Hay I.D., Gorman C.A., Offord K.P., Scanion P.W. Radioidine-induced hypothyroidism in Graves\u2019 disease: Factors associated with the increasing incidence. J. Nucl. Med. 23: 978, 1982.","journal-title":"J. Nucl. Med."},{"key":"BF03346913_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","volume":"75","author":"MT McDermott","year":"1983","unstructured":"McDermott M.T., Kidd G.S., Dodson L.E., Hofeldt F.D. Radioiodine-induced thyroid storm. Case report and literature review. Am. J. Med. 75: 353, 1983.","journal-title":"Am. J. Med."},{"key":"BF03346913_CR12","first-page":"86","volume":"89","author":"MA Taher","year":"1991","unstructured":"Taher M.A., Loken M.K., Bantle J.P. Radioiodine therapy in thyroxicosis. J. Indian Med. Assoc. 89: 86, 1991.","journal-title":"J. Indian Med. Assoc."},{"key":"BF03346913_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9343(99)80137-5","volume":"99","author":"HL Uy","year":"1995","unstructured":"Uy H.L., Reasner C.A., Samuels M.H. Pattern of recovery of the hypothalamic-pituitary-thy-roid axis following radioiactive iodine therapy in patients with Graves\u2019 disease. Am. J. Med. 99: 173, 1995.","journal-title":"Am. J. Med."},{"key":"BF03346913_CR14","first-page":"103","volume":"4","author":"J Bertelsen","year":"1992","unstructured":"Bertelsen J., Herskind A.M., Sprog\u00f8e Jakobsen U., Hegedus L. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative? Thyroidol. Clin. Exp. 4: 103, 1992.","journal-title":"Thyroidol. Clin. Exp."},{"key":"BF03346913_CR15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(75)92071-1","volume":"ii","author":"PH Wise","year":"1975","unstructured":"Wise P.H., Burnet R.B., Ahmad A., Harding P.E. Intentional radioiodine ablation in Graves\u2019 disease. Lancet ii: 1231, 1975.","journal-title":"Lancet"},{"key":"BF03346913_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.0954-6820.1985.tb01634.x","volume":"217","author":"E Eriksson","year":"1985","unstructured":"Eriksson E., Eriksson K., Wahlberg P. Treatment of hyperthyroidism with standard doses of radioiodine aiming at ablation. Acta Med. Scand. 217: 55, 1985.","journal-title":"Acta Med. Scand."},{"key":"BF03346913_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H., Fischer C., Bogner U., Reiners C., Schleusener H. Radioiodine therapy of Graves\u2019 hyperthyroidism: standard vs calculated 131iodine activity. Results from a prospective, randomized, multicentre study. Eur. J. Clin. Invest. 25: 186, 1995.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03346913_CR18","first-page":"87","volume":"38","author":"AE Jarl\u00f8v","year":"1991","unstructured":"Jarl\u00f8v A.E., Hegedus L., Gj\u00f8rup T., Hansen J.E.M. Accuracy of the clinical assessment of thyroid size. Dan. Med. Bull. 38: 87, 1991.","journal-title":"Dan. Med. Bull."},{"key":"BF03346913_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-121-8-199410150-00001","volume":"121","author":"HB Burch","year":"1994","unstructured":"Burch H.B., Solomon B.L., Wartofsky L., Burman K.D. Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves\u2019 disease. Ann. Intern. Med. 121: 553, 1994.","journal-title":"Ann. Intern. Med."},{"key":"BF03346913_CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/jcem-50-2-226","volume":"50","author":"JSA Sawers","year":"1980","unstructured":"Sawers J.S.A., Toft A.D., Irvine W.J., Brown N.S., Seth J. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. J. Clin. Endocrinol. Metab. 50: 226, 1980.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346913\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:11:29Z","timestamp":1565309489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BF03346913"],"URL":"https:\/\/doi.org\/10.1007\/bf03346913","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}